Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
阿司匹林对小鼠脑动脉瘤的作用机制
基本信息
- 批准号:8738727
- 负责人:
- 金额:$ 16.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Inflammation appears to play a critical role in the formation of cerebral aneurysms, their progression to rupture- prone type, and ultimately to rupture. Evidence supporting this hypothesis includes recent data from human neurosurgery patients and experimental animal models demonstrating that aneurysm wall tissue is rich with macrophages and inflammatory molecules. To investigate potential therapeutic implications of this hypothesis, I carried out a retrospective study examining whether patients with ruptured cerebral aneurysms who took aspirin had a reduced risk of aneurysm rupture. This study was performed using the International Study of Unruptured Intracranial Aneurysms data base. Patients who used aspirin three times weekly to daily have a significantly decreased risk of aneurysm rupture. My current scientific goals, and the subject of this proposal, are to study the molecular mechanisms by which inflammation influences cerebral aneurysm formation and rupture. I am using the well-established Hashimoto mouse aneurysm model to pursue two specific aims. In Specific Aim 1, I will determine the contributions of COX-1 and COX-2 to the protective effect of aspirin against aneurysm rupture. In Specific Aim 2, I will determine the cell
type associated with activation of the COX-2 pathway resulting in a protective effect against aneurysm rupture. These studies will involve the use of complementary genetic, pharmacological and bone marrow transplantation experimental approaches. Knowledge of the inflammation related molecular mechanisms of aneurysm formation and rupture will provide information that is critical to the development of effective new medical therapies for patients wit this dangerous cerebrovascular disease.
描述(由申请人提供):炎症似乎在脑动脉瘤的形成中起着关键作用,其发展为破裂类型,最终是破裂的。支持该假设的证据包括来自人类神经外科患者的最新数据和实验动物模型,表明动脉瘤壁组织富含巨噬细胞和炎症分子。为了研究该假设的潜在治疗意义,我进行了一项回顾性研究,研究了服用阿司匹林的脑动脉瘤破裂的患者是否降低了动脉瘤破裂的风险。这项研究是使用国际颅内动脉瘤数据库的国际研究进行的。每周三次使用阿司匹林的患者每天的动脉瘤破裂风险大大降低。我目前的科学目标以及该提案的主题是研究炎症影响脑动脉瘤形成和破裂的分子机制。我正在使用良好的Hashimoto小鼠动脉瘤模型来追求两个具体目标。在特定的目标1中,我将确定COX-1和COX-2对阿司匹林对动脉瘤破裂的保护作用的贡献。在特定的目标2中,我将确定单元格
类型与COX-2途径的激活相关,从而对动脉瘤破裂产生保护作用。这些研究将涉及互补的遗传,药理和骨髓移植实验方法的使用。了解与炎症相关的动脉瘤形成和破裂的分子机制的知识将提供有关这种危险脑血管疾病的有效新医疗疗法至关重要的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
David M. Hasan其他文献
Campomelic dysplasia: A rare cause of congenital spinal deformity
- DOI:10.1016/j.jocn.2009.09.01310.1016/j.jocn.2009.09.013
- 发表时间:2010-05-012010-05-01
- 期刊:
- 影响因子:
- 作者:Nader S. Dahdaleh;Gregory W. Albert;David M. HasanNader S. Dahdaleh;Gregory W. Albert;David M. Hasan
- 通讯作者:David M. HasanDavid M. Hasan
Anomalous origins of the calcarine and parieto-occipital arteries
- DOI:10.1016/j.jocn.2010.04.00310.1016/j.jocn.2010.04.003
- 发表时间:2010-10-012010-10-01
- 期刊:
- 影响因子:
- 作者:Karthik Madhavan;Brian J. Dlouhy;Timothy W. Vogel;Bruno A. Policeni;Wendy R.K. Smoker;David M. HasanKarthik Madhavan;Brian J. Dlouhy;Timothy W. Vogel;Bruno A. Policeni;Wendy R.K. Smoker;David M. Hasan
- 通讯作者:David M. HasanDavid M. Hasan
Symptomatic carotid artery intraluminal thrombus: risk of medical management failure and distal embolization
有症状的颈动脉腔内血栓:医疗管理失败和远端栓塞的风险
- DOI:
- 发表时间:20232023
- 期刊:
- 影响因子:4.8
- 作者:D. Schartz;Stephen Susa;N. Ellens;S. Akkipeddi;Clifton Houk;Tarun Bhalla;T. Mattingly;David M. Hasan;M. BenderD. Schartz;Stephen Susa;N. Ellens;S. Akkipeddi;Clifton Houk;Tarun Bhalla;T. Mattingly;David M. Hasan;M. Bender
- 通讯作者:M. BenderM. Bender
Multiple intra-aneurysmal WEB devices: Case discussions and operative technique
- DOI:10.1016/j.jocn.2020.08.00310.1016/j.jocn.2020.08.003
- 发表时间:2020-10-012020-10-01
- 期刊:
- 影响因子:
- 作者:Joseph S. Hudson;Mario Zanaty;Jorge A. Roa;Pascal Jabbour;Edgar A. Samaniego;David M. HasanJoseph S. Hudson;Mario Zanaty;Jorge A. Roa;Pascal Jabbour;Edgar A. Samaniego;David M. Hasan
- 通讯作者:David M. HasanDavid M. Hasan
Anterior-to-Posterior Circulation Approach for Mechanical Thrombectomy of an Acutely Occluded Basilar Artery Using the Penumbra Aspiration System
- DOI:10.1016/j.wneu.2011.04.02510.1016/j.wneu.2011.04.025
- 发表时间:2012-02-012012-02-01
- 期刊:
- 影响因子:
- 作者:Wei Liu;David K. Kung;Kelly B. Mahaney;James D. Rossen;Pascal M. Jabbour;David M. HasanWei Liu;David K. Kung;Kelly B. Mahaney;James D. Rossen;Pascal M. Jabbour;David M. Hasan
- 通讯作者:David M. HasanDavid M. Hasan
共 5 条
- 1
David M. Hasan的其他基金
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
- 批准号:1067778510677785
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
- 批准号:1063702310637023
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly: NIA SCORE
症状性颈动脉闭塞血管内再通的神经认知损伤评估:NIA SCORE
- 批准号:1063425910634259
- 财政年份:2020
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
- 批准号:1004698510046985
- 财政年份:2020
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
使用去铁酮改善蛛网膜下腔出血的认知结果:U-DISCO
- 批准号:1022256610222566
- 财政年份:2020
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
15-PGDH 是比阿司匹林更好的治疗靶点,可同等降低男性和女性颅内动脉瘤破裂的风险
- 批准号:1058453410584534
- 财政年份:2019
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
15-PGDH 是比阿司匹林更好的治疗靶点,可同等降低男性和女性颅内动脉瘤破裂的风险
- 批准号:98884559888455
- 财政年份:2019
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
15-PGDH 是比阿司匹林更好的治疗靶点,可同等降低男性和女性颅内动脉瘤破裂的风险
- 批准号:1056923410569234
- 财政年份:2019
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
阿司匹林对小鼠脑动脉瘤的作用机制
- 批准号:89157798915779
- 财政年份:2013
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
阿司匹林对小鼠脑动脉瘤的作用机制
- 批准号:86349158634915
- 财政年份:2013
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
- 批准号:1066772610667726
- 财政年份:2023
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
TREM2 senses both pathogen- and damage-associated molecular patterns to promote S. aureus craniotomy infection
TREM2 感知病原体和损伤相关分子模式以促进金黄色葡萄球菌开颅感染
- 批准号:1042576110425761
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
- 批准号:1050407710504077
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
Matricellular protein CCN3 in vascular homeostasis
基质细胞蛋白 CCN3 在血管稳态中的作用
- 批准号:1066251810662518
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别:
T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection
T细胞先天免疫串扰调节金黄色葡萄球菌开颅感染
- 批准号:1059063410590634
- 财政年份:2022
- 资助金额:$ 16.79万$ 16.79万
- 项目类别: